Fatty Liver Disease Clinical Trial
Official title:
Prevelance of Non Alcoholic Fatty Liver Disease,Its Complications Among Employees at Banha University Hospital,Egypt
This was cross sectional study at Banha University Hospital among employees. Age of the subjects from 20-60 years old both males and females .All investigations done plus abdominal ultrasound for grading of fatty liver and dopler for carotid intima media thickness.
This cross-sectional study was conducted on employees working for the Benha University
Hospitals, Qalubeyia Governorate, Egypt. The study population comprised both male and female
employees (20 to 60 years old) with no history of viral hepatitis(HBV,HCV) and
autoimmune-liver diseases such as primary sclerosing cholangitis and primary billiary
cirrhosis . The field work was carried out from September 2018 to March 2019.
This study was approved by the Research Ethics Committee in Benha Faculty of Medicine. An
informed consent (in Arabic language) was obtained from all participants. It included all
details about the study (title, objectives, methods, expected benefits and risks, and
confidentiality of data).
Subjects:
The sample size for the study was calculated according to the following equation 1:
"Sample size" = (〖Z_(1-∝/2)〗^(2 ) P(1-P))/d^2 Where
Z 1-α/2 = standard normal deviate; (at 5% type I error (P<0.05) it is 1.96). P=expected
proportion in population based on previous studies 2. d= absolute error or precision (0.05).
The total number of the study participants was 165 subjects, who confirm with the inclusion
criteria and agreed to participate in the study. These were selected by the systematic random
sampling technique.
Data collection tools:
An arranged interview with every study participant was carried out at the Hepatology and
Gastrointestinal Department of the Benha University Hospital. All the study participants were
exposed to full history taking and clinical examination. Venous blood samples after fasting
for 10 hours were collected for complete blood counting, and the assessment of fasting blood
glucose, fasting insulin, HOMA-IR test by soecific equation , liver functions testing
(ALT,AST ,GGT &Alk.Phosphatase) . kidney functions testing(Serum Urea & Serum Creatinine )
and lipid profile include (serum cholesterol, very low density and high density lipoprotein.
Assessment of Liver Fatty Acid Binding Protein (L-FABP), , was carried out using ELIZA.
Abdominal Ultrasound for grading of fatty liver from grade 1 to grade 3 according to the
comparison with echogencity of right kidney and Doppler on external carotid artery were
performed to measure the the intima media thickness.
the different study groups were carried out using the Chi-square test (X2) and the Fisher
Exact test (FET) to compare proportions as appropriate. The Student t-test (t) and the
Mann-Whitney test (MW) were used to compare two groups of quantitative data regarding
parametric and non-parametric data, respectively. While the Kruskal Wallis test and One-Way
Analysis Of Variance (ANOVA; F) were used to compare more than two groups, followed by
post-hock testing using the Bonferroni method to detect differences in pairs. Spearman
correlation coefficient (rho) and Pearson correlation coefficient (r) were used to assess the
correlation between the studies parameters as appropriate. the diagnostic performance of
L-FAB, HOMA-IR and CIT for NAFLD was examined and the best cut-off and the corresponding
Sensitivity, Specificity, Positive Predictive Value (PPV), Negative Predictive Value and Area
Under the Curve were estimated. Statistical significance was accepted at P value <0.05 (S).
The statistical analysis was conducted using STATA/SE version 11.2 for Windows (STATA
corporation, College Station, Texas).
All the peoples from age 20-60 years old both males and females will be included , apparently
healthy either obese or not from banha university employees and students.
They will be evaluated clinically and examined as follow :
- Blood pressure , body mass index(BMI)=heigh/weigh2
- Invesigations as follow , complete blood count(CBC), fasting blood sugar ,glycosyated
haemoglobin (HbA1c),Liver function tests including alaninie aminotransferease (ALT)
,aspartateaminotransferase(AST),gamma glutamyl transpeptidase (GGT),alkaline phosphatase
,serum bilirubin, and serum albumin.
lipid profile including (cholesterol,triglycerides,HDL,C and LDL).
- Serum insulin level for calculating insulin resistance (IR) Homostasis Model Assay for
Insulin Resistant(HOMA-IR) was assessed using the given mathematical equation; HOMA-IR ¼
fasting insulin (mU/ml) fasting plasma glucose (mmol/l)/22.5 . A HOMA value of 2.18,
signifies IR Fatty Acid Binding protein1 (FABP1)
- FABP1 was evaluated after the patient fasting 8 hours by the enzyme-linked immunosorbent
assay (ELISA) according to George Haltern ,et al 2010 and the deviation from the normal
will be correlated with other investigations and clinical manifestations of the
subjects.
- Abdominal Ultrasound was done for grading of fatty liver , to 3 grades from grade 1 to
grade3 in comparison to right kidney and diphragm . .
- Carotid Intimal Media Thickenss(CIMT) measured for extracranial portion of Carotid artey
by Colour Dopler by measure while the patiet in recumbancy at45 degree and the probe
must be in angle less than 90 degree to get the correct results ..
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05881005 -
NAC- NAFLD And Cushing
|
N/A | |
Recruiting |
NCT05220956 -
Impact of Time-restricted Feeding in NAFLD
|
N/A | |
Enrolling by invitation |
NCT04066608 -
Prevalence of Advanced Fibrosis in Patients Living With HIV
|
||
Recruiting |
NCT04302051 -
Assessment of Fatty Liver With Thermo-acoustic Device
|
||
Recruiting |
NCT04496895 -
The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults
|
N/A | |
Recruiting |
NCT05880316 -
Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting
|
N/A | |
Active, not recruiting |
NCT05898841 -
Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load
|
Phase 4 | |
Completed |
NCT05764811 -
SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With Obesity
|
N/A | |
Active, not recruiting |
NCT05076058 -
Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver
|
N/A | |
Recruiting |
NCT05421572 -
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
|
||
Recruiting |
NCT06302049 -
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis
|
Phase 1/Phase 2 | |
Completed |
NCT04283942 -
Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism
|
N/A | |
Completed |
NCT01016418 -
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
|
Phase 1/Phase 2 | |
Terminated |
NCT04175392 -
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04191044 -
Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
|
||
Not yet recruiting |
NCT06071923 -
Effect of Thyroid Disorders in Liver Diseases
|
||
Recruiting |
NCT04525833 -
Liver Disease and Other Systemic Diseases
|
||
Not yet recruiting |
NCT05966025 -
Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
|
Phase 2 | |
Completed |
NCT04844450 -
A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795
|
Phase 1 | |
Completed |
NCT05694923 -
Effect of Sodium Glucose Cotransporter Inhibitors on Non Diabetic Fatty Liver Disease Patients
|
N/A |